Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎

Bibliographic Details
Title:	Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎
Authors:	Palandri, Francesca, Palumbo, Giuseppe A., Iurlo, Alessandra, Polverelli, Nicola, Benevolo, Giulia, Breccia, Massimo, Abruzzese, Elisabetta, Tiribelli, Mario, Bonifacio, Massimiliano, Tieghi, Alessia, Isidori, Alessandro, Martino, Bruno, Sgherza, Nicola, D'Adda, Mariella, Bergamaschi, Micaela, Crugnola, Monica, Cavazzini, Francesco, Bosi, Costanza, Binotto, Gianni, Auteri, Giuseppe, Latagliata, Roberto, Ibatici, Adalberto, Scaffidi, Luigi, Penna, Domenico, Cattaneo, Daniele, Soci, Francesco, Trawinska, Malgorzata, Russo, Domenico, Cuneo, Antonio, Semenzato, Giampietro, Di Raimondo, Francesco, Aversa, Franco, Lemoli, Roberto M., Heidel, Florian, Reggiani, Maria L.B., Bartoletti, Daniela, Cavo, Michele, Catani, Lucia, Vianelli, Nicola
Source:	In Seminars in Hematology October 2018 55(4):248-255
Database:	ScienceDirect